Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250403065196N1Phase 3Completed
Phase 3 trial of pyridoxine in chronic kidney disease (CKD), xerostomia and hypertension (HTN), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Change in dry mouth severity and Change in blood pressure. Started May 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250403065196N1.